Search
for
Sort by
Research 331–360 of 1000+
- Identifying effective immune biomarkers in alopecia areata diagnosis based on machine learning methods
- Alopecia areata: a comprehensive review of clinical, immunologic, and genetic perspectives
- Increased proliferation of epidermal gamma delta T cells and expression of the transmembrane protein, BST2, in Alopecia areata
- [Significance of HLA-DR+ T cells and natural killer (NK) cells in the peripheral blood lymphocytes of alopecia areata (AA)].
- Role of topical tofacitinib in autoimmune skin disorders: An expert opinion
- Use of oral Janus kinase inhibitors for the treatment of severe alopecia areata: narrative review and real-world experience
- Clinicopathological Features and Pathogenesis of Thymoma Complicated with Alopecia Areata: A Multicenter, Matched Case Analysis
- 0150 Single-cell and spatial transcriptome profiling reveals innate-adaptive crosstalk in alopecia areata
- Alopecia areata in solid organ transplant recipients: A retrospective analysis
- ALOPECIA AREATA: ASPECTOS FISIOLÓGICOS E AVANÇOS TERAPÊUTICOS – UMA REVISÃO DE LITERATURA
- ALOPECIA AREATA PROFILING SHOWS LNCRNAS REGULATE THE SUPPRESSED EXPRESSION OF KERATIN.
- 801 TEC family kinase inhibitors as a novel class of therapeutics in alopecia areata
- 148 Decreased IL-10 producing regulatory B cells in patients with alopecia areata
- Alopecia areata
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
- Potential Herbal Medicine for Alopecia Areata Treatment : A Systematic Review
- Evaluation of serum Level of Human Beta Defensin 1 patients With Alopecia Areata
- Diagnosis and treatment of local forms of alopecia areata in children
- Atopic dermatitis and risk of autoimmune diseases: a systematic review and meta-analysis
- Comparison of Current International Guidelines for the Management of Alopecia Areata—Comprehensive Review
- Alopecia areata: current concepts
- Gene Array Profiling and Immunomodulation Studies Define a Cell-Mediated Immune Response Underlying the Pathogenesis of Alopecia Areata in a Mouse Model and Humans
- Transient CD44 Variant Isoform Expression and Reduction in CD4+/CD25+ Regulatory T Cells in C3H/HeJ Mice with Alopecia Areata
- Deciphering the Complex Immunopathogenesis of Alopecia Areata
- The Genetic Architecture of Alopecia Areata
- A “hair‐raising” history of alopecia areata
- Identification of differentially expressed miRNAs in alopecia areata that target immune-regulatory pathways
- Systemic Autoimmune Diseases
- Possible role of β‐hydroxybutyrate in inducing inflammation in alopecia areata
- The role of B cell-activating factor system in autoimmune diseases: mechanisms, disease implications, and therapeutic advances